CURRENT TEAM Mark Howarth, Professor of Protein Nanotechnology

Mark did graduate work in molecular immunology at Oxford University Institute of Molecular Medicine and Southampton

University Cancer Sciences. In his postdoctoral work at MIT he developed tools in chemical biology, advanced microscopy and

nanotechnology to understand receptor trafficking. He has been a PI at Oxford since 2007. In 2017 he was awarded the Royal

Society of Chemistry Norman Heatley Prize for chemical biology. He is a founder of SpyBiotech, which is now running clinical trials

for a Covid-19 vaccine, and Director of Entrepreneurship for the Biochemistry Department. His work has been funded by ERC,

BBSRC, EPSRC, MRC, Wellcome Trust and through collaborations with companies including AB Vista, Sekisui Diagnostics and Sony.

Sheryl Lim, DPhil student

Sheryl did her undergraduate training at Imperial College London. In Singapore she researched therapeutic targeting of tumour

suppressors and came to Oxford in 2018 on an A*STAR studentship. In the Howarth lab she has co-developed the NeissLock

system, towards long-lasting therapeutic delivery.

Anthony Keeble, PhD from UEA

Anthony is applying library selection and structure-based design to the engineering of fast-reacting and unbreakable protein


Niels Wicke, DPhil student

Niels, originally from Germany, did his BSc at the University of Edinburgh and came to Oxford as part of the Interdisciplinary

Biosciences Doctoral Training Programme. He has an iCASE studentship with AB Vista and is establishing evolutionary platforms and

proteins allowing targeting in the gastrointestinal system. While in Oxford, he co-founded Inulox and mentored Oxford’s iGEM team.

Claudia Driscoll, DPhil student

Claudia did her undergraduate training at Durham University and joined Oxford’s Interdisciplinary Bioscience DTP. She is

developing new antibody architectures.

Hung-Jen Wu, DPhil student

Hung-Jen originally trained in Economics and Mathematics and then did an MSci on DNA methylation in cancer at Georgetown

University. He is enhancing the generation and design of nanoparticles to improve immune responses and vaccination.

Jamie Lam, Part II student

Jamie is advancing bispecific antibody technology.

Dominic Wood, DPhil student

Dominic studied Biology at the University of York and took part in the iGEM competition in 2017. He is currently on the

Interdisciplinary Bioscience DTP.

Rory Hills, DPhil student

Rory studied at the University of Victoria, Canada where he established the University Synthetic Biology club and devised

analytical technology related to the opioid overdose crisis. He is a Rhodes Scholar, developing new vaccine technologies.

Susan Vester

Susan did her doctoral work at King’s College London on innate immune sensing and autoimmune disease. She is currently

establishing protein switching technologies.

Vincent Fideli, Part II student

Vincent is studying how to improve therapeutic delivery to the GI tract.

Henry Wood

Henry studied enzyme structural biology at the University of Sheffield and is developing protein nanoassembly approaches.

Lasya Vankayala, DPhil student

Lasya studied at the University of British Columbia, where she founded COVID19 Demystified, and is developing covalent

conjugation to enhance cell therapy.

For information on joining this lab.


Jayati Jain, co-founder with Trutech Webs and the Fluid Motion

Kanlaya Prapainop, Assistant Prof. at Mahidol University, Thailand

Miriam O’Duill, Assistant Prof. at University of Nottingham

Anne-Marie Andersson, CTO at vaccine/immunotherapy spin-out InProTher

Theodora Bruun, Stanford Medical School

Denis Krndija, Group leader at Centre de Biologie Intégrative (CBI), Toulouse

Robert Wieduwild, researcher at Rudolf-Schönheimer-Institut für Biochemie, University of Leipzig, and founder of

spin-out denovoMATRIX

Apurba Koner, Associate Prof. at Indian Institute of Science Education and Research

Rolle Rahikainen, University of Tampere

Bijan Zakeri at BASF

Irsyad Khairil Anuar, founder at LiliumX

Arne Scheu, founder at LiliumX

Sarah Rouse UKRI Future Leaders Fellow at Imperial College London

Jacob Fierer, Director of Business Development, Technology transfer

at Weizmann Institute

Gianluca Veggiani at University of Toronto

Michael Fairhead at Structural Genomics Consortium, University of Oxford

Paul Moody at Oxford Nanopore

Catharina Melzer at Boston Consulting Group

Alberto Carella at Micklefield lab, University of Manchester

Anselm Schneider at Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin

Felix Metzner, Gene Center at Ludwig Maximilian University of Munich

Christopher Schoene at Hoffmann Eitle Patent

Emily Chittock at Carpmaels & Ransford Intellectual Property

Linda Tchatchouang at GenScript

Sam Stokes at UK Intellectual Property Office

David Schramm at Oxford University Medical School

James Ross at University of Leeds

Karl Brune, founder at Genie Biotech and consultant

Can Buldun at Roche

Anthony Walsh at Mission Biocapital

Raphael Gayet in Jim Collins lab at MIT

Georgi Nikov at Imperial College

Michael Jacobsen at Navigen Pharmaceuticals and Adjunct Assistant Professor, University of Utah

Anusuya Banerjee at Oxford Nanoimaging

MH Claudia Anthony Niels Sheryl Hung-Jen Susan
ADDRESS Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU UK
CONTACT e: t: 01865 613200
2021 Mark Howarth. All rights reserved.
Dominic Rory Vincent Jamie Henry Lasya